Pelargonium sidoides extract for the treatment of acute bronchitis;Pelargonium-sidoides-extrakt bei akuter bronchitis

KIM - Komplementare und Integrative Medizin, Artztezeitschrift fur Naturheilverfahren

Volumn 48, Issue 4, 2007, Pages 35-39

  Schulz, Volker ^a,b  

^a Arzt für Innere Medizin ^*  (Germany)

^b Dranionburger   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPS 7630; PELARGONIUM SIDOIDES EXTRACT; PENICILLIN G; PLACEBO; PLANT EXTRACT; UMCKALOABO; UNCLASSIFIED DRUG;

ARTICLE; BRONCHITIS; CLINICAL TRIAL; HUMAN; MEDICINAL PLANT; PELARGONIUM; PELARGONIUM SIDOIDES; PHYTOTHERAPY;

EID: 35048892169     PISSN: 18638678     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Anonymus. Periodic Safety Update Report on the Tolerability of Pelargonium sidoides Extract EPs 7630. Ettlingen: ISO Pharma; 2004.
2. Blochin B, Haidvogl M, Heger M. Umckaloabo im Vergleich zu Acetylcystein bei Kindern mit akuter Bronchitis. Der Kassenarzt 1999;49:46-49.
3. Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a Pelargonium sidoides preparation (EPs® 7630): A randomized, double-blind, placebo-controlled trial. Explore 2005;1:437-445.
4. Conrad A, Schulz V. Umckaloabo bei akuter Bronchitis. Dtsche Apoth Z 2007;147:75-79
5. Dietl R, Müller J. Anwendungsbeobachtung gemäß § 67.6 AMG mit EPs 7630. Biometrischer Bericht. Karlsruhe: Schwabe Arzneimittel GmbH; 2002.
6. Haidvogl M, Heger M, Barti BJ. Treatment of Acute Bronchitis in Children with EPs® 7630-Solution in Comparison with Acetylcysteine: A Randomized, Multicenter, Double-Blind Double Dummy Active Comparator Controlled Study. 2007, in preparation
7. Haidvogl M, Heger M. Treatment Effect and Safety of EPs® 7630 solution in Acute Bronchitis in Childhood - Report of a multicentre observational study. Phytomed Suppl VI 2007;14:60-64
8. Koch E. Untersuchungen zu möglichen hepatotoxischen Effekten von Umckaloabo®. Z Phytother 2006;27:25.
9. Koch K, Biber A. Treatment of rats with the Pelargonium sidoides extract EPs® 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin. Phytomed Suppl VI 2007;14:40-45
10. Kolodziej H, Schulz V. Umckaloabo. Dtsche Apotheker Z 2003;143:1303-1312.
11. Matthys H, Heger M. Treatment of Acute Bronchitis with a Liquid Herbal Drug Preparation from Pelargonium sidoides (EPs® 7630): A Randomised, Double-Blind, Placebo-Controlled, Multi-Centre Study. 2007; Current Medical Research and Opinion 2007;23:323-331.
12. Matthys H, Kamin W, Funk P, Heger M. Pelargonium sidoides preparation (EPs® 7630) in the treatment of acute bronchitis in adults and children. Phytomed Suppl VI 2007;14:69-73
13. Nöldner M, Schötz K. Inhibition Of Lipopolysaccharid-Induced Sickness Behavior By A Dry Extract From The Roots Of Pelargonium Sidoides (EPs® 7630) in Mice. Phytomed Suppl VI 2007;14:27-31
14. Roots I, Arold G, Dienel, A, Meng. G, Wollny A, Bauer S. Placebokontrollierte doppelblinde Interaktionsstudie mit Pelargonium-sidoides- Extrakt und Penicillin V bei gesunden Probanden. Kongress Phytopharmaka und Phytotherapie 2004 - Forschung und Praxis, Berlin 2004.
15. Schötz K, Nöldner M. Mass spectroscopic characterization of oligomeric proanthocyanidins derived from an extract of Pelargonium sidoides roots (EPs® 7630) and pharmacological screening in CNS models. Phytomed Suppl VI 2007;14:32-39